Common Questions in the treatment of Venous Thromboembolism

What does the 2020 NICE guidance say about acute management of VTE and extended VTE treatment?

How should you extend DOACs treatment, how long would you use the treatment and what factors do you consider?

What type of cancer patients do you select for DOACs and what factors do you consider?

When it comes to cancer associated thrombosis, what is the duration of treatment that you consider?

What is the guidance around the use of DOACs in extremes of body weight?

What factors do you consider when choosing a DOAC?

What are the benefits of the three week dosing?

Speaker: